Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus

Molecular Brain Research

Volumn 41, Issue 1-2, 1996, Pages 140-147

  Wardlaw, Sharon L ^a   Kim, Jennie ^a   Sobieszczyk, Sylwester ^a  

^a Columbia Univ Coll of Phys and S ^*  (United States)

Author keywords

Hypothalamus; Morphine; Proopiomelanocortin; Melanocyte stimulating hormone; Endorphin

Indexed keywords

ALPHA INTERMEDIN; BETA ENDORPHIN; CORTICOSTERONE; ESTRADIOL; MESSENGER RNA; MORPHINE; OPIATE; POTASSIUM CHLORIDE; PROOPIOMELANOCORTIN; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DRUG DEPENDENCE; DRUG EFFECT; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RADIOIMMUNOASSAY; RAT; RNA HYBRIDIZATION; STEROID RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030571053     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(96)00084-8     Document Type: Article

References (33)

1. Akil H., Watson S.J., Young E., Lewis M.E., Khachaturian H., Walker J.M. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7:1984;223-255.
2. Beaulieu S., Gagne B., Barden N. Glucocorticoid regulation of proopiomelanocortin messenger ribonucleic acid content of rat hypothalamus. Mol. Endocrinol. 2:1988;727-731.
3. Berglund L.A., Millington W.R., Simpkins J.W. Gonadal steroid and chronic morphine treatment do not change the postranslational processing of β-endorphin in the rat brain. Life Sci. 44:1989;591-601.
4. Blum M., Roberts J.L., Wardlaw S.L. Androgen regulation of proopiomelanocortin gene expression and peptide content in the basal hypothalamus. Endocrinology. 124:1989;2283-2288.
5. Bronstein D.M., Przewlocki R., Akil H. Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res. 519:1990;102-111.
6. Bronstein D.M., Day N.C., Gutstein H.B., Trujillo K.A., Akil H. Pre- and posttranslational regulation of β-endorphin biosynthesis in the CNS: effects of chronic naltrexone treatment. J. Neurochem. 60:1993;40-49.
7. Buckingham J.C., Cooper T.A. Differences in hypothalamopituitary-adrenocortical activity in rat after acute and prolonged treatment with morphine. Neuroendocrinology. 38:1984;411-417.
8. Chowen-Breed J., Fraser H.M., Vician L., Damassa D.A., Clifton D.K., Steiner R.A. Testosterone regulation of proopiomelanocortin messenger ribonucleic acid in the arcuate nucleus of the male rat. Endocrinology. 124:1989;1697-1702.
9. Cicero T.J. Effects of exogenous and endogenous opiates on the hypothalamic-pituitary-gonadal axis in the male. Fed. Proc. 39:1980;2551-2554.
10. Cintra A., Bortolotti F. Presence of strong glucocorticoid receptor immunoreactivity within hypothalamic and hypophyseal cells containing pro-opiomelanocortic peptides. Brain Res. 577:1992;127-133.
11. Garcia de Yebenes E., Pelletier G. Opioid regulation of proopiomelanocortin (POMC) gene expression in the rat brain as studied by in situ hybridization. Neuropeptides. 25:1993;91-94.
12. Gudehithlu K.P., Tejwani G.A., Bhargava H.N. β-Endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats. Brain Res. 553:1991;284-290.
13. Hollt V., Przewlocki R., Herz A. β-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates. Life Sci. 23:1978;1057-1066.
14. Jaffe S.B., Sobieszczyk S., Wardlaw S.L. Effect of opioid antagonism on β-endorphin processing and proopiomelanocortin-peptide release in the hypothalamus. Brain Res. 648:1994;24-31.
15. Kelly M.J., Loose M.D., Ronnekleiv O.K. Opioids hyperpolarize β-endorphin neurons via μ-receptor activation of a potassium conductance. Neuroendocrinology. 52:1990;268-275.
16. Koenig J.I., Meltzer H.Y., Gudelsky G.A. Morphine or capsaicin administration alters the secretion of beta-endorphin into the hypophysial portal vasculature of the rat. Neuroendocrinology. 43:1986;611-617.
17. Krieger D.T., Liotta A.S., Brownstein M.J., Zimmerman E.A. ACTH, β-lipotropin, and related peptides in brain, pituitary, and blood. Rec. Prog. Horm. Res. 36:1980;277-343.
18. l'Héreault S., Barden N. Regulation of proopiomelanocortin messenger RNA concentrations by opioid peptides in primary cell cultures of rat hypothalamus. Mol. Brain Res. 10:1991;115-121.
19. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
20. Markowitz C.E., Berkowitz K.M., Jaffe S.B., Wardlaw S.L. Effect of opioid receptor antagonism on proopiomelanocortin peptide levels and gene expression in the hypothalamus. Mol. Cell Neurosci. 3:1992;184-190.
21. Mocchetti I., Ritter A., Costa E. Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats. J. Mol. Neurosci. 1:1989;33-38.
22. Meites J., Bruni J.F., Van Vugt D.A., Smith A.F. Relation of endogenous opioid peptides and morphine to neuroendocrine functions. Life Sci. 24:1979;1325-1336.
23. Nicolas P., Li C.H. β-Endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia. Proc. Natl. Acad. Sci. USA. 82:1985;3178-3181.
24. Nikolarakis K.E., Almeida O.F.X., Herz A. Feedback inhibition of opioid peptide release in the hypothalamus of the rat. Neuroscience. 23:1987;143-148.
25. Przewlocki R., Hollt V., Duka T.H., Kleber G., Gramsch C.H., Haarmann I., Herz A. Long-term morphine treatment decreases endorphin levels in rat brain and pituitary. Brain Res. 174:1979;357-361.
26. Ragavan V.V., Wardlaw S.L., Kreek M.J., Frantz A.G. Effect of chronic naltrexone and methadone administration on brain immunoactive β-endorphin in the rat. Neuroendocrinology. 37:1983;266-268.
27. Tong Y., Couet J., Simard J., Pelletier G. Glucocorticoid regulation of proopiomelanocortin mRNA levels in rat arcuate nucleus. Mol. Cell. Neurosci. 1:1990;78-83.
28. Treiser S.L., Wardlaw S.L. Estradiol regulation of proopiomelanocortin gene expression and peptide content in the hypothalamus. Neuroendocrinology. 55:1992;167-173.
29. Wardlaw S.L., Thoron L., Frantz A.G. Effects of sex steroids on brain β-endorphin. Brain Res. 245:1982;327-331.
30. Wardlaw S.L. Regulation of β-endorphin, corticotropin-like intermediate lobe peptide, and α-melanotropin-stimulating hormone in the hypothalamus by testosterone. Endocrinology. 119:1986;19-24.
31. Wilcox J.N., Roberts J.L. Estrogen decreases rat hypothalamic proopiomelanocortin messenger ribonucleic acid levels. Endocrinology. 117:1985;2392-2396.
32. Wise P.M., Scarborough K., Weiland N.G., Larson G.H. Diurnal pattern of proopiomelanocortin gene expression in the arcuate nucleus of proestrous, ovariectomized, and steroid-treated rats: a possible role in cyclic luteinizing hormone secretion. Mol. Endocrinol. 4:1990;886-892.
33. Wuster M., Schultz R., Herz A. Inquiry into endorphinergic feedback mechanisms during the development of opiate tolerance/dependence. Brain Res. 189:1980;403-411.